Dr. Azad Kumar Singh et al. 2025. IMPACT OF TYPE 2 DIABETES MELLITUS ON RIFAMPICIN PHARMACOKINETICS AND BIOCHEMICAL PATHWAYS IN PULMONARY TUBERCULOSIS PATIENTS. Journal of Population Therapeutics and Clinical Pharmacology. 32, 7 (Aug. 2025), 1149–1153. DOI:https://doi.org/10.53555/gcv48408.